This 3D animation explains how folate receptor alpha (FRα) antibody-drug conjugates (ADCs) work to treat ovarian cancer. It walks through the mechanism of action—from targeting cancer cells to delivering a cytotoxic payload—and highlights how ADCs can impact even antigen-low tumors through the bystander effect. Ideal for clinicians and learners looking to understand the science behind FRα-directed therapies.
This activity is supported by an independent educational grant from Genmab US, Inc.